Original Article : Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional Constipation

논문상세정보
' Original Article : Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional Constipation' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • constipation
  • microbiome
  • probiotics
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
540 0

0.0%

' Original Article : Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional Constipation' 의 참고문헌

  • U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact
    Drossman DA Dig Dis Sci 38 : 1569 ~ 1580 [1993]
  • The role of probiotic cultures in the control of gastrointestinal health
    Rolfe RD J Nutr 130 : 396S ~ 402S [2000]
  • The role of a probiotics mixture in the treatment of childhood constipation: a pilot study
    Bekkali NL Nutr J 6 : 17 ~ [2007]
  • The intestinal ecosystem in chronic functional constipation
    Zoppi G Acta Paediatr 87 : 836 ~ 841 [1998]
  • Systematic review of randomised controlled trials: probiotics for functional constipation
    Chmielewska A World J Gastroenterol 16 : 69 ~ 75 [2010]
  • Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
    Verdú EF Gut 55 : 182 ~ 190 [2006]
  • Review article: bifidobacteria as probiotic agents−physiological effects and clinical benefits
    Picard C Aliment Pharmacol Ther 22 : 495 ~ 512 [2005]
  • Randomised clinical trial:efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation−a double-blind, controlled, crossover study
    Riezzo G Aliment Pharmacol Ther 35 : 441 ~ 450 [2012]
  • Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation
    Koebnick C Can J Gastroenterol 17 : 655 ~ 659 [2003]
  • Molecular analysis of commensal host-microbial relationships in the intestine
    Hooper LV Science 291 : 881 ~ 884 [2001]
  • Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
    Carroll IM Gut Pathog 2 : 19 ~ [2010]
  • Intestinal microflora stimulates myoelectric activity of rat small intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex
    Husebye E Dig Dis Sci 39 : 946 ~ 956 [1994]
  • Intestinal flora in health and disease
    Simon GL Gastroenterology 86 : 174 ~ 193 [1984]
  • Interdigestive myoelectric complex in germ-free rats
    Caenepeel P Dig Dis Sci 34 : 1180 ~ 1184 [1989]
  • How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form
    Heaton KW Gut 32 : 73 ~ 79 [1991]
  • Hemostasis in children with dysbacteriosis in chronic constipation
    Kirgizov IV Clin Appl Thromb Hemost 7 : 335 ~ 338 [2001]
  • Gut flora in health and disease
    Guarner F Lancet 361 : 512 ~ 519 [2003]
  • Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome
    Chassard C Aliment Pharmacol Ther 35 : 828 ~ 838 [2012]
  • Effects of yogurt supplemented with brewer's yeast cell wall on constipation and intestinal microflora in rats
    Nakamura T J Nutr Sci Vitaminol 47 : 367 ~ 372 [2001]
  • Effects of probiotic Lactobacillus paracasei-enriched artichokes on constipated patients: a pilot study
    Valerio F J Clin Gastroenterol 44 (suppl 1) : S49 ~ S53 [2010]
  • Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons
    Kleessen B Am J Clin Nutr 65 : 1397 ~ 1402 [1997]
  • Effect of probiotics on gastrointestinal function: evidence from animal models
    Verdú EF Therap Adv Gastroenterol 2 : 31 ~ 35 [2009]
  • Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly
    Ouwehand AC Ann Nutr Metab 46 : 159 ~ 162 [2002]
  • Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women
    Yang YX World J Gastroenterol 14 : 6237 ~ 6243 [2008]
  • Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults
    Waller PA Scand J Gastroenterol 46 : 1057 ~ 1064 [2011]
  • Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut
    Suau A Appl Environ Microbiol 65 : 4799 ~ 4807 [1999]
  • Demonstration of safety of probiotics- a review
    Salminen S Int J Food Microbiol 44 : 93 ~ 106 [1998]
  • Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation
    Agrawal A Aliment Pharmacol Ther 29 : 104 ~ 114 [2009]
  • Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women:a double-blind, randomized, controlled study
    Marteau P Aliment Pharmacol Ther 16 : 587 ~ 593 [2002]
  • Bacteroides: the good, the bad, and the nitty-gritty
    Wexler HM Clin Microbiol Rev 20 : 593 ~ 621 [2007]
  • Bacteria and gastrointestinal secretion and motility
    Borriello SP Scand J Gastroenterol Suppl 93 : 115 ~ 121 [1984]
  • Analyzing real-time PCR data by the comparative C(T) method
    Schmittgen TD Nat Protoc 3 : 1101 ~ 1108 [2008]
  • Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR
    Malinen E Am J Gastroenterol 100 : 373 ~ 382 [2005]
  • Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation
    Khalif IL Dig Liver Dis 37 : 838 ~ 849 [2005]
  • Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome
    Nobaek S Am J Gastroenterol 95 : 1231 ~ 1238 [2000]
  • A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
    Kim HJ Aliment Pharmacol Ther 17 : 895 ~ 904 [2003]